Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
FDA Approves Asenapine Sublingual Tablets for Expanded Use in Schizophrenia, Bipolar Disorder  
 
Share |
Merck announces FDA approval for expanded adult use of its asenapine sublingual tablets to now include maintenance treatment for schizophrenia and as adjunctive therapy for bipolar 1 disorder. Medscape Medical News
Read from Source
 Submitted on: Sep 14 2010/ 2 yearss ago
 Submitted By : NewsBot in Health
 Views : 73
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator